IN 1912 O'Connorl demonstrated that serum
had a vasoconstrictor activity that was distinctly greater than that of plasma and was not due to epinephrine. Janeway and coworkers2 found that platelets were essential to the vasoconstrictor activity of serum. This observation was later confirmed by several other investigators.3' 4In 1948, a crystalline vasoconstrictor substance was isolated from serum by Rapport and associates5' 6 and named "serotonin." This substance, subsequently identified as 5-hydroxytryptamine, 7-' is derived biologically from tryptophan."1
The presence of serotonin in high concentration within platelets and its absence from normal platelet-free plasma suggest the possibility that this compound may play a role in hemostatic mechanisms that in turn may influence cardiovascular function. The huge amounts of serotonin associated with metastatic carcinoid are presumed to be related to at least some of the cardiovascular disturbances associated with this disease. '2' 13 This paper presents the results of experiments designed to determine whether serotonin is involved in clotting or hemostasis, and
From the Third (NYU) Medical Division, Goldwater Memorial Hospital, New York, N. Y., and the Section of Chemical Pharmacology, National Heart Institute, Bethesda, Md.
Supported in part by a grant from the New York Heart Association.
353
whether the concentration of circulating serotonin is altered in a variety of disease states. METHODS Platelet suspensions were prepared from blood collected and handled with siliconized glassware. Disodium ethylenediamine tetracetate (EDTA) was used as anticoagulant (0.3 ml. of 5.0 per cent Na, EDTA to 9.7 ml. of blood). Platelet counts were done by direct chamber count with a diluent containing 1.5 per cent Na2 EDTA and 0.7 per cent NaCl. After determination of the platelet count of the whole blood specimen, the blood was centrifuged for 20 min. at 500 r.p.m. The plasma was separated from the red cells and recentrifuged at 2000 r.p.m. for 40 min. The supernatant was then decanted and the platelet button resuspended in 3.3 ml. of isotonic saline. The platelet count of this suspension was determined and 3.0-ml. aliquots were used to determine the serotonin content spectrophotofluorometrically.'4 This procedure can measure as little as 0.1 ,ug. of serotonin.
In vitro coagulation studies were performed on plasma specimens obtained from a mixture of 1 part 3.8 per cent sodium citrate to 9 parts of blood. The recalcification time was done by adding 0.1 ml. of 0.025 M. CaCl2 to a mixture of 0.1 ml. plasma and 0.1 ml. water or appropriate serotonin solution. Prothrombin time was performed by a 1- struction of thrombin by antithrombin. Consequently, the capacity of serum of a specific age to clot fibrinogen is a function of both the initial amount of thrombin formed and the antithrombin activity. The test is performed with serum from the system used to measure prothrombin by the 1-stage technic. If the initial prothrombin time is normal, it is assumed that a normal amount of thrombin was formed and that residual thrombin after a specific time interval is a function of antithrombin activity.
Prothrombin time is done in the usual way with the aid of a nichrome wire loop, which is left in the tube as the clot forms. Exactly 30 seconds after clotting, the clot is lifted with the wire loop and gently compressed against the glass wall to obtain serum. The clot is then removed and exactly 1 minute after clotting, 0.1 ml. of the residual serum is added to 0.2 ml. of standard fibrinogen solution (Chilcott). Normally the fibrinogen will clot in 12 to 18 seconds. Higher clotting times indicate increased antithrombin activity if initial prothrombin time is normal.
Fibrinolysis was studied by the method of von Kaulla.'1 Observations were also made with the coagulograph ("Thromboelastograph" of Hartert19), an instrument that records continuously the distensibility of a clot. 20 Capillary fragility was determined in patients by counting the petechiae produced by negative pressure of 20 mm. Hg applied for 2 minutes to the volar surface of the forearm 2 inches below the antecubital fossa.
RESULTS
Influence of Serotonin on the Clotting Tests. The recalcification time, prothrombin time, 
